These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 165830

  • 1. The effect of ADP, calcium and some inhibitors of platelet aggregation on protein phosphokinases from human blood platelets.
    Bishop GA, Rozenberg MC.
    Biochim Biophys Acta; 1975 Mar 28; 384(1):112-9. PubMed ID: 165830
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate and protein kinase.
    Käser-Glanzmann R, Jakäbovä M, George JN, Lüscher EF.
    Biochim Biophys Acta; 1977 May 02; 466(3):429-40. PubMed ID: 192295
    [Abstract] [Full Text] [Related]

  • 3. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C, Dubernard V, Caen J.
    Eur J Biochem; 1984 Aug 01; 142(3):465-71. PubMed ID: 6088225
    [Abstract] [Full Text] [Related]

  • 4. Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes.
    Lips JP, Sixma JJ, Schiphorst ME.
    Biochim Biophys Acta; 1980 Apr 03; 628(4):451-67. PubMed ID: 6245712
    [Abstract] [Full Text] [Related]

  • 5. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C.
    Am J Pathol; 1976 Dec 03; 85(3):581-94. PubMed ID: 998732
    [Abstract] [Full Text] [Related]

  • 6. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 03; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 7. Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
    Cusack NJ, Hourani SM.
    Br J Pharmacol; 1982 Feb 03; 75(2):397-400. PubMed ID: 7186826
    [Abstract] [Full Text] [Related]

  • 8. Control of platelet glycogenolysis; Activation of phosphorylase kinase by calcium.
    Gear AR, Schneider W.
    Biochim Biophys Acta; 1975 May 05; 392(1):111-20. PubMed ID: 164952
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN, Sinha AK.
    Biochim Biophys Acta; 1989 Aug 21; 984(1):113-8. PubMed ID: 2548620
    [Abstract] [Full Text] [Related]

  • 10. Effects of D- and L- enantiomers of adenosine, AMP and ADP and their 2-chloro- and 2-azido- analogues on human platelets.
    Cusack NJ, Hickman ME, Born GV.
    Proc R Soc Lond B Biol Sci; 1979 Nov 30; 206(1163):139-44. PubMed ID: 42919
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
    Harrison MJ, Brossmer R.
    Thromb Haemost; 1976 Nov 30; 36(2):388-91. PubMed ID: 1036839
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ, Davidson MM, Desjardins JV.
    Biochem J; 1978 Oct 15; 176(1):83-95. PubMed ID: 215136
    [Abstract] [Full Text] [Related]

  • 13. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW.
    Biochim Biophys Acta; 1977 Aug 25; 499(1):48-60. PubMed ID: 196670
    [Abstract] [Full Text] [Related]

  • 14. Adenosine cyclic 3',5'-monophosphate-dependent protein kinase from human platelets.
    Booyse FM, Marr J, Yang DC, Guiliani D, Rafelson ME.
    Biochim Biophys Acta; 1976 Jan 23; 422(1):60-72. PubMed ID: 174739
    [Abstract] [Full Text] [Related]

  • 15. [Effect of calcium, thrombin and nucleotides (ADP, cAMP, cGMP) on blood platelet glycolysis and energy metabolism].
    Nikulin AA.
    Farmakol Toksikol; 1980 Jan 23; 43(5):585-90. PubMed ID: 6256208
    [Abstract] [Full Text] [Related]

  • 16. Characterisation of ADP receptors.
    Cusack NJ, Hourani SM, Welford LA.
    Adv Exp Med Biol; 1985 Jan 23; 192():29-39. PubMed ID: 3010670
    [No Abstract] [Full Text] [Related]

  • 17. Effects of four types of reagents on ADP-induced aggregation and Ca2+ mobilization of bovine blood platelets.
    Kitagawa S, Endo J, Kametani F.
    Biochim Biophys Acta; 1984 Apr 10; 798(2):210-5. PubMed ID: 6324876
    [Abstract] [Full Text] [Related]

  • 18. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ, Rosson GM.
    Mol Pharmacol; 1975 Sep 10; 11(5):528-44. PubMed ID: 170501
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of aggregation inducers and inhibitors on the pentosephosphate pathway enzymes of glucose conversion in the thrombocytes].
    Nikulin AA, Aksenova VM, Petrovich IuA.
    Farmakol Toksikol; 1979 Sep 10; 42(3):254-7. PubMed ID: 221244
    [Abstract] [Full Text] [Related]

  • 20. Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium.
    Vigdahl RL, Marquis NR, Tavormina PA.
    Biochem Biophys Res Commun; 1969 Oct 22; 37(3):409-15. PubMed ID: 4310667
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.